Have you caught up on the new FDA Diversity Action Plan? At a high level, the Diversity Action Plan aims to increase enrollment and retention of clinically relevant study populations in clinical research by ensuring adequate representation of study participants that reflect different age groups, geographic locations, gender identities, sexual orientations, socioeconomic statuses, physical and mental disabilities, and more. Advarra's Luke Gelinas recently weighed in on the potential impact FDA guidance will have on the industry, along with fellow experts Pamela Tenaerts, MD, MBA (Medable) and Pam D. (Curavit). Watch or read their interview here in Applied Clinical Trials Magazine: https://lnkd.in/ekihe6Dx #ClinicalResearch #ClinicalTrials #DEI
Advarra’s Post
More Relevant Posts
-
Save the date and join SWHR CEO and President Kathryn Godburn Schubert at the #thINc360 conference in Washington DC this summer to discuss opportunities for innovations in #healthcare, #research, and #science! #WomensHealthResearchDay
January 25th is Women’s Health Research Day, which "marks the implementation of the NIH Sex as a Biological Variable Policy, which outlines NIH’s expectation that sex as a biological variable will be factored into research designs, analyses, and reporting." In honor of Women's Health Research Day today, The Healthcare Innovation Company (thINc) is thrilled to announce that Kathryn Godburn Schubert, MPP, CAE, President and CEO of the Society for Women's Health Research (SWHR), joined the stellar lineup of speakers at The Healthcare Innovation Congress (thINc360) taking place from May 29-31, 2024, in Washington, DC. Kathryn (Katie) Schubert has been at the helm of SWHR since April 2020, where she has played a pivotal role in advancing the organization's mission of promoting research on biological sex differences in disease and enhancing women’s health through science, policy, and education. Under Katie’s dynamic leadership, SWHR has crafted a strategic plan that focuses on making significant strides in women's health. Her previous experience at the The Society for Maternal-Fetal Medicine, where she served as the chief advocacy officer, reflects her commitment to growing organizations and building a strong reputation in women's health on a national scale. Katie is not only a trusted leader but also a consensus builder in the realm of women’s health, especially within the policy arena. Her contributions extend beyond SWHR, with multiple board roles for nonprofit organizations in the Washington, DC area, including serving as Chair of the Board of the Maternal Mental Health Leadership Alliance (MMHLA) Alliance and advising the John E. Lewy Fund for Children’s Health. She has also held the prestigious position of past president of Women in Government Relations. Don't miss the chance to hear from this influential leader in women’s health! Early bird registration is now open. Register by Friday, January 26, 2024 and save an extra $100 off the lowest rate available with promo code SM2024.* (That's up to $800 off the final rates.) 👉 Register Now: https://lnkd.in/d3YTmxHJ #thINc360 #HealthcareInnovation #healthcare #FutureofHealthcare #health #healthandwellness #HealthcareLeadership #healthpolicy #LeadershipInHealthcare #WomenInHealth #womenhealth #womenshealth #WomensHealthResearchDay
To view or add a comment, sign in
-
The Continuing Professional Development (CPD) focus for 2023/24 is on Equality, Diversity and Inclusion. We'd love to hear your thoughts to the questions posed in the following clinical scenario. This is an open and inclusive conversation, designed to help chiropractors consider how to integrate and embed the behaviour of inclusion and diversity into their practice. All participants are encouraged to share their response without fear of judgment, evaluation, or any negative consequences for their contributions. ⬇️ 🗣️ A 48-year-old (cis)woman attends your clinic with pelvic pain. She loves socialising at the pub with her wife, but is now finding sitting on the bar stools uncomfortable. She records in her documentation that she has a past medical history of hypertension, depression, and a family history of cervical cancer. She tells you that she is taking antidepressants. 1️⃣ What clinical concerns should you have in relation to her family history of cervical cancer? 2️⃣ Why should cervical screening be a particular concern for you in relation to the care of lesbian and bisexual women? Either comment below, or leave your thoughts anonymously on this form: https://lnkd.in/eBQ2gutX and we will publish your comment on your behalf. We will shortly be publishing a link to all the previous scenarios, alongside some of the points to consider, on our website. We will comment below when this is live.
To view or add a comment, sign in
-
🌟 New Research Alert! 🌟 I'm excited to share my latest publication: "(Mis)Gendering Bleeding Disorders Care: A Qualitative Case Study of a Trans Person with a Bleeding Disorder." (https://lnkd.in/g_4KDzkv) The case study highlights some of the unique challenges faced by transgender individuals living with bleeding disorders. The Key findings include: 🔹 The gendered nature of health care excludes and disadvantages minority groups, including the trans and non-binary communities. 🔹 The need for healthcare professionals to receive training on gender diversity and inclusivity. 🔹 The necessity to include the trans and non-binary community in the design, implementation and delivery of services. I hope this research sparks meaningful discussions and drives positive changes in healthcare policies and practices. Thank you to everyone who made this study possible. #TransHealth #BleedingDisorders #InclusiveHealthcare #GenderDiversity #PatientCare #HealthcareResearch
To view or add a comment, sign in
-
Unraveling the Mediating Role of Frailty: Understanding Health Care Utilization among Older Sexual and Gender Minority Adults in the All of Us Research Program #OHDSISocialShowcase #JoinTheJourney Lead: Chelsea N Wong Team: Louisa H. Smith, Rob Cavanaugh, Brianne Olivieri-Mui, PhD, MPH Background: Older sexual and gender minorities (OSGM) have a higher burden of frailty and mental health conditions compared to non-SGM older adults (non-OSGM). Evidence from New York City suggests, OSGM are twice as likely to utilize mental health care compared to non-OSGM. Moreover, frailty among non-OSGM has been linked to higher utilization of health care, including general doctor visits, hospitalizations, and emergency department visits. However, the extent to which frailty impacts the relaAonship between OSGM status and health care uAlizaAon is poorly understood. Therefore, the aim of this study was to establish whether frailty acts as a mediator between sexual and gender minority (SGM) status and use of general doctor visits and mental health visits. Our hypothesis posits that individuals who are not frail will demonstrate a weaker positive association between OSGM status and healthcare utilization. https://lnkd.in/eGF5jGtJ
Unraveling the Mediating Role of Frailty: Understanding Health Care Utilization among Older Sexual and Gender Minority Adults in the All of Us Research Program
https://www.ohdsi.org
To view or add a comment, sign in
-
As puberty blockers are experimental, the actual effects are not known. It’s good to read the The American College of Pediatricians advice based on experience. (Last link on the post) Mike Gouin thanks for this source: https://lnkd.in/g2rcdjT4 #harmreduction #illegal to #experimemt on children. I Would hope so. Now I am not an idiot to keep it at this: Biomedical experimentation involving humans subjects https://lnkd.in/gf7s2CYG Behaviour altercations and the criminal law https://lnkd.in/gTpD42yW Both state section 7 and 12 in the Canadian charter rights. Which protects against experimentation and also considers the state of the child, as an example being forced. (Woke extremist parents) Also Quebec has clearly stated that an minor would have to get parental consent with superior court judge approval showing no harm with evidence. There is a lot of international laws due to WW2 and it’s defined. This ends the discussion I think. It’s law? I want individuals to understand laws are created to protect us. Honourable Danielle Smith yes, you are in the right and it’s heroic. She is more closer to the law that protects us.
Transgender Interventions Harm Children
acpeds.org
To view or add a comment, sign in
-
The National Health Service (N.H.S.) in England has implemented new restrictions on gender treatments for children, becoming the fifth European country to do so. The decision comes after a four-year review conducted by Dr. Hilary Cass, an independent pediatrician, which highlighted a lack of evidence regarding the benefits of these treatments and raised concerns about potential long-term harms. The report concluded that, for most young people, a medical pathway may not be the best approach to managing gender-related distress. As a result, the N.H.S. will no longer offer puberty-blocking drugs, except for patients involved in clinical research. The report also advises extreme caution when prescribing hormones like testosterone and estrogen, which induce permanent physical changes, to minors. It's important to note that these guidelines do not apply to doctors in private practice. This move by England reflects a broader trend in northern Europe, where health officials have observed a significant increase in demand for adolescent gender treatments. Finland, Sweden, Norway, and Denmark have also implemented restrictions on these treatments, emphasizing alternative approaches such as psychotherapy as the primary treatment for adolescents with gender dysphoria. While some transgender advocacy groups have criticized these changes, citing concerns about civil rights and strained healthcare systems, the decision in England aims to address the growing challenges faced by the healthcare system. #GenderTreatmentRestrictions #HealthcareChanges #YouthGenderHealth #EuropeanApproach #AlternativeApproaches #thesocialtalks
To view or add a comment, sign in
-
Research at Harm Reduction International Conference - Cutting Edge Survey Analysis Exciting News! A groundbreaking research initiative took place during HRI23 in Melbourne. Esteemed scholars from Karolinska Institute , AHRN, Best Shelter, and AHRA practitioners joined forces for an operational research meeting on women and girls impacted by drug use and sex work. Cutting-edge analysis of female health surveys revealed insights on sociodemographic characteristics, prevalent risk behaviors, and adverse health outcomes. Our aim? To transform programmatic decisions and service delivery for our female clients and communities. Tailoring harm reduction interventions to marginalized populations is key to making a tangible difference. With these insights, we can develop evidence-based programming, allocate resources effectively, and uplift the health and well-being of these remarkable women and girls. Stay tuned for more updates as we create a healthier, more inclusive world! #HealthResearch #InclusionMatters #TransformingCommunities
To view or add a comment, sign in
-
Founding Director, Women’s Age Lab, Women’s College Hospital, Professor of Medicine and Public Health and RTO/ERO Chair, University of Toronto.
Are you in the process of writing a health research proposal? Or reviewing health research proposals? Integrating sex and gender in health research is essential to produce the best possible evidence to inform health care, and improve patient outcomes. Explore tips on how researchers can strengthen the integration of sex and gender in their studies, and create stronger funding proposals. Based on this paper by Suzanne Day, PhD, Robin Mason PhD, and Dr. Cara Tannenbaum and myself. Learn more here: https://lnkd.in/ekEe9NCR #Research #Healthcare #WomensAgeLab Women's College Hospital, PLOS, Ontario SPOR SUPPORT Unit (OSSU), University of Toronto, Temerty Faculty of Medicine, University of Toronto, Public Health Agency of Canada | Agence de la santé publique du Canada
To view or add a comment, sign in
-
Why is it essential to fight against systemic racism and stereotypes in healthcare and psychology? In the fields of healthcare, our actions have a direct impact on the lives and well-being of the people we serve. However, despite our best intentions, unconscious biases can influence our decisions, compromising the quality of care and reinforcing existing inequalities. Research has shown that these biases can lead to the misassessment of symptoms, diagnostic errors, and inadequate treatments, particularly among racialized populations ("Mediterranean syndrome"). For instance, some studies have demonstrated that the pain of patients of color is often underestimated, or that patients from ethnic minorities are less likely to receive appropriate psychiatric treatments compared to their white counterparts. As healthcare professionals, we must acknowledge these biases and actively confront them. This involves: - Continuous education, not only on the technical aspects of our profession but also on implicit biases and how they affect our decisions. - Commitment to equitable care practices, ensuring that each patient receives the attention, respect, and treatment they deserve, regardless of their ethnic or social background. - Support for research and policies aimed at eliminating disparities in healthcare and promoting equal access for all. Eliminating barriers related to systemic racism is not only a matter of social justice but also a necessity to ensure quality care and improve outcomes for all our patients. #EquitableHealth #Psychology #FightAgainstRacism #Healthcare #Equality #Inclusion #SocialJustice
To view or add a comment, sign in
-
New research is the first to use an intersectional approach to examine disparities in the completion of alcohol treatment, finds striking gender and race-based inequities. A recent study, led by researchers at PHI's Alcohol Research Group (ARG), found completion rates for alcohol treatment are significantly lower for racially and ethnically minoritized women compared to white men. The study sought to measure disparities in treatment completion more precisely by using an intersectional approach that examined race, gender, and ethnicity together and compared the results when measured by race and ethnicity alone and gender alone. Read more -- https://lnkd.in/gRpk7BhK #Research #AlcoholTreatment #IntersectionalHealthcare
Hidden Inequities: Intersectional Study Uncovers Stark Disparities in Substance Use Treatment Completion Among Women of Color - Public Health Institute
phi.org
To view or add a comment, sign in
50,571 followers
Human Subjects Research Protection Expert
3moThe FDA's Diversity Action Plan will help to ensure that clinical research is stronger, through well-rounded equitable data, outcomes, solutions, and better treatment options. It is time to make the advancement of healthcare beneficial for everyone.